Inventor · disambiguated record
David Andre Baptiste Maussang-Detaille
Also filed as: MAUSSANG-DETAILLE DAVID ANDRE BAPTISTE · MAUSSANG-DETAILLE DAVID ANDRÉ BAPTISTE
6 granted patents·5 pending applications·11 citations·filing 2012–2024
75Inventor score
Top patents by PatentIndex Score
11 records- 0195US12247078B2ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2024·Granted Mar 11, 2025·3 cites·20 claims
- 0286US11780925B2ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 0385US12195551B2Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancerMERUS NV·Filed 2018·Granted Jan 14, 2025·3 cites·9 claims
- 0478US2024199747A1Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion geneMERUS NV·Filed 2023·Application pending·0 cites
- 0557US9994639B2Biological materials related to CXCR7ABLYNX NV·Filed 2013·Granted Jun 12, 2018·0 cites·8 claims
- 0657US9758584B2Biological materials related to CXCR7ABLYNX NV·Filed 2014·Granted Sep 12, 2017·0 cites·20 claims
- 0753US2018355048A1Biological materials related to cxcr7ABLYNX NV·Filed 2018·Application pending·0 cites
- 0847US2021206875A1Erbb-2 targeting agent and a bispecific antibody with antigen-binding sites that bind an epitope on an extracellular part of erb-2 and erbb-3, for treatment of an individual with an erbb-2, erbb-2/erbb-3 positive tumourMERUS NV·Filed 2018·Application pending·0 cites
- 0947US2015158948A9Bispecific anti-cxcr7 immunoglobulin single variable domainsDESCAMPS FRANCIS·Filed 2012·Application pending·0 cites
- 1043US2020291130A1Antibodies for the treatment of erbb-2/erbb-3 positive tumorsMERUS NV·Filed 2018·Application pending·0 cites
- 1142US9512236B2Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disordersABLYNX NV·Filed 2012·Granted Dec 6, 2016·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when David Andre Baptiste Maussang-Detaille files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →